Followers | 256 |
Posts | 18838 |
Boards Moderated | 3 |
Alias Born | 12/02/2014 |
Sunday, August 21, 2022 1:00:05 PM
Recent communications @OfficialVXIT:
Jun 28, 2022
In New York this week looking to close additional acquisitions for Virexit, meeting with investment bankers today, hoping to provide more updates this week as they become available $VXIT
FORM 1-A REGULATION A OFFERING STATEMENT
https://www.otcmarkets.com/filing/html?id=15844047&guid=tek-kHQIg8RSJth
NOTICE OF QUALIFICATION
https://www.otcmarkets.com/filing/html?id=15864318&guid=tek-kHQIg8RSJth
Jun 29, 2022
Good afternoon $VXIT shareholders. We are pleased to announce a new company website will be coming online shortly to better reflect our incoming acquisitions.
Jul 15, 2022
New York meetings went well. $VXIT is writing up a LOl with a great opportunity out of Israel we look forward to sharing details once signed. The company continues the due diligence phase on several ventures & plans on issuing press
releases throughout the 2nd half of 2022.
https://twitter.com/OfficialVXIT
07/11/2022 Quarterly Report - Financials for Quarter ended 5/31/22
NOTE 11 – SUBSEQUENT EVENTS
Management has evaluated subsequent events through July 12, 2022, which is the date when these consolidated financial statements were
issued, and is aware of none requiring disclosure, except as noted below.
In June 2022, the Company issued Convertible notes in exchange for $75,000. The notes are due in ninety days from the date of
the note. Repayment is to be in the amount of $93,750. In addition the note holders received 37,500,000, one year $0.002
warrants. The notes also carry a conversion option, election is at the option of the note holder, to convert the note or any portion
of the note into common stock shares. Conversion is to be calculated at 75% of the lowest trading price during the ten trading
day period prior to the conversion date.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM